Mehul Desai Joins Enable Injections as VP, Medical Affairs
Mehul Desai Joins Enable Injections as VP, Medical Affairs We are pleased to announce Mehul Desai, […]
Enable Injections Enhances Board with Addition of John DeFord, Ph.D.
New director, John DeFord, Ph.D., adds global medical technology experience to Enable Injections, strengthening its mission […]
New Look, Same Mission – enFuse®
Enable Injections is excited to introduce the new look for the enFuse® lid. The new enFuse […]
Enable Injections Enhances Board with Addition of Three New Directors
New directors add meaningful operating, investing and delivery systems experience to Enable Injections, strengthening its mission […]
Large-Volume Wearable Drug Delivery Technology Is Clinically Proven
Opening Summary Does large-volume wearable drug delivery technology really work? And is it clinically proven? Experts […]
Large-Volume Subcutaneous Delivery Is Feasible
Current large-volume drug delivery methods generally require the patient and provider to be in the clinic. […]
At-Home Drug Delivery of Large Molecule Medicines – The Future Is Now
At-Home Drug Delivery of Large Molecule Medicines Current large volume drug delivery methods generally require the […]
Large-Volume Subcutaneous Delivery
Large-Volume Subcutaneous Delivery Clinical summary on the accuracy, safety, and efficacy of large-volume subcutaneous delivery Why […]
Sanofi announces partnership with Enable Injections, Inc. on subcutaneous delivery for Sarclisa®
In a press release today, Sanofi announces partnership with Enable Injections, Inc. on subcutaneous delivery for […]
Russell Pagano Joins Enable Injections as VP, Regulatory Affairs
Russell Pagano Joins Enable Injections as VP, Regulatory Affairs We are pleased to announce Russell Pagano, […]
Reducing the Treatment Burden on Nurses
New Technology Allows Hands-free Drug Delivery In September 2021, the American Nurses Association (ANA) published an […]
Enable Injections Announces $215 Million Financing
New financing provides significant financial flexibility to propel growth efforts, benefitting patients, providers, and pharma partners […]